Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.600
-0.090 (-3.35%)
At close: Oct 30, 2026, 4:00 PM EDT
2.590
-0.010 (-0.38%)
After-hours: Oct 30, 2026, 4:10 PM EDT
Apyx Medical Market Cap
Apyx Medical has a market cap or net worth of $109.52 million as of October 30, 2026. It is the 24,414th most valuable company in the world and the 4,016th biggest in the United States. Its market cap has decreased by 1.86% in one year.
Market Cap
109.52M
Enterprise Value
121.54M
1-Year Change
-1.86%
Global Rank
Country Rank
#4,016 United States
Category
ChartMarket Cap Chart
Since February 22, 1999, Apyx Medical's market cap has increased from $10.20M to $109.52M, an increase of 973.75%. That is a compound annual growth rate of 8.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 109.50M | -18.16% |
| Dec 31, 2025 | 133.80M | 144.61% |
| Dec 31, 2024 | 54.70M | -39.76% |
| Dec 29, 2023 | 90.80M | 12.10% |
| Dec 30, 2022 | 81.00M | -81.60% |
| Dec 31, 2021 | 440.30M | 78.40% |
| Dec 31, 2020 | 246.80M | -14.63% |
| Dec 31, 2019 | 289.10M | 34.34% |
| Dec 31, 2018 | 215.20M | 151.99% |
| Dec 29, 2017 | 85.40M | -13.12% |
| Dec 30, 2016 | 98.30M | 72.15% |
| Dec 31, 2015 | 57.10M | -13.62% |
| Dec 31, 2014 | 66.10M | 72.58% |
| Dec 31, 2013 | 38.30M | -10.93% |
| Dec 31, 2012 | 43.00M | 14.36% |
| Dec 30, 2011 | 37.60M | -35.28% |
| Dec 31, 2010 | 58.10M | -56.48% |
| Dec 31, 2009 | 133.50M | 31.92% |
| Dec 31, 2008 | 101.20M | 2.64% |
| Dec 31, 2007 | 98.60M | -26.20% |
| Dec 29, 2006 | 133.60M | 221.93% |
| Dec 30, 2005 | 41.50M | 17.90% |
| Dec 31, 2004 | 35.20M | -12.87% |
| Dec 31, 2003 | 40.40M | 213.18% |
| Dec 31, 2002 | 12.90M | 21.70% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MaxCyte | 164.10M |
| Quanterix | 137.39M |
| Perspective Therapeutics | 131.27M |
| Pulmonx | 129.06M |
| Owlet | 118.35M |
| Nyxoah | 90.91M |
| Sera Prognostics | 80.48M |
| Lucid Diagnostics | 77.30M |